C13. Mechanisms of Disease in Human Asthma 2009
DOI: 10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a3921
|View full text |Cite
|
Sign up to set email alerts
|

The Severe Asthma Phenotype Is Characterized by Elevated Levels of Formate in Exhaled Breath Condensate.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2011
2011
2011
2011

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…1,7,35 Additionally, S-nitrosoglutathione (GSNO) metabo- determinant of asthmatic airway acidifi cation. 18,42,43 Therefore, the subset of patients with increased GSNO reductase activity might be predicted to have low F e NO and low EBC pH. One way or another, this subset appears to be biochemically unique and may be a subset in which the metabolomically targeted therapy (for example, with inhaled base 7,35 ) may be particularly benefi cial.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…1,7,35 Additionally, S-nitrosoglutathione (GSNO) metabo- determinant of asthmatic airway acidifi cation. 18,42,43 Therefore, the subset of patients with increased GSNO reductase activity might be predicted to have low F e NO and low EBC pH. One way or another, this subset appears to be biochemically unique and may be a subset in which the metabolomically targeted therapy (for example, with inhaled base 7,35 ) may be particularly benefi cial.…”
Section: Discussionmentioning
confidence: 99%
“…A subpopulation of patients with chronic cough who have consistently low EBC pH on serial studies at home appear to be those patients whose cough can be successfully treated with high-dose proton pump inhibitor therapy. 18 However, the fi nding is based on a subjective questionnaire. Prospective studies will be needed to determine whether a specifi c EBC pH will be useful in predicting responses to antacid-class therapies in asthma.…”
Section: Discussionmentioning
confidence: 99%